Preview

Urology Herald

Advanced search

TECHNIQUE OF EXTRACORPOREAL PARTIAL NEPHRECTOMY IN TERMS OF PHARMACO-COLD ISCHEMIA WITHOUT CROSSING THE URETER WITH RENAL VESSELS ORTHOTOPIC REPLANTATION IN PATIENTS WITH RENAL CELL CARCINOMA

https://doi.org/10.21886/2308-6424-2015-0-3-3-33

Abstract

Background. The most difficult is to determine medical tactics in patients with renal cell carcinoma (RCC) with intraparenchimal and central localization in the single, the only functioning kidney, as well as with a combination of tumor and other illnesses in contralateral kidney. Partial nephrectomy leading to renal replacement therapy results in life-threatening complications and poor prognosis. The priority is to develop organ-preserving treatment: from minimally invasive endoscopic surgery to ex vivo kidney resection. Aim: to develop a technique of extracorporeal partial nephrectomy in terms of pharmaco-cold ischemia without crossing the ureter with renal vessels orthotopic replantation in patients with RCC. Materials and methods. The study included 37 patients with pT1a-T3vN0M0-1G1-3 RCC with intraparenchymal and central tumor location. The average age of the patients was 55.32 ± 13.1 years. The ratio of men and women - 2.7:1. Bilateral renal tumors were observed in 3 (8.1%) patients, and the RCC of the single functioning kidney in 6 (16.2%) patients. One patient (2.7%) was diagnosed RCC of a single kidney with intraluminal invasion (cava-renal form). Results. The mean operation time was 413.97 ± 89.14 minutes. The mean warm ischemia time – 8.39 ± 4.75 minutes. Cold ischemia lasted from 70 to 240 minutes, on the average 151.41 ± 41.29 min. The amount of blood loss made up 729.03 ± 481.4 ml. Perioperative complications were detected in 3 (8.1%) patients. In two cases after starting the renal blood flow the kidney was found to be nonviable and had to be removed. And in one case the recurrent prosthetic thrombosis of the renal artery resulted in a renal scarring. Postoperative complications were observed in 18 (48.6%) patients. According to Clavien-Dindo classification there were 8 low grade (I-II degree) complications (44.4%), 8 other of III degree, and one IV degree complication, and there was one lethal case (V degree). Conclusion. Extracorporeal partial nephrectomy in terms of pharmaco-cold ischemia without crossing the ureter with orthotopic renal vessels replantation in patients with RCC is a relatively safe organ-preserving treatment. The long period of cold ischemia allows one to perform the resection stage of any complexity and duration. This technique gives the possibility to remove tumor larger than 40 mm and of any location. Extended resections up to one-stage excision of solitary kidney with thrombectomy from inferior vena cava and the inferior vena cava resection are possible and safe. The proposed technique allows one to put the kidney back into its place with the orthotopic renal vessels replantation and excludes the complementary access with the consequent loss of time for dissection and autologous transplantation of kidney in the iliac region. Moreover, there is no necessity to cross the ureter and to make uretero-ureteroanastomosis, uretero-cystoanastomosis.

About the Authors

Alexander Gritskevitch
ФГБУ «Институт хирургии им. А.В. Вишневского» МЗ РФ
Russian Federation


S. Il'in
A.V. Vishnevsky Institute of Surgery, Moscow, Russia
Russian Federation


Irina Timina
A.V. Vishnevsky Institute of Surgery, Moscow, Russia
Russian Federation


Andrey Zotikov
A.V. Vishnevsky Institute of Surgery, Moscow, Russia
Russian Federation


Grigoriy Karmazanovskiy
A.V. Vishnevsky Institute of Surgery, Moscow, Russia
Russian Federation


Alexander Teplov
A.V. Vishnevsky Institute of Surgery, Moscow, Russia
Russian Federation


A. Pokrovskiy
A.V. Vishnevsky Institute of Surgery, Moscow, Russia
Russian Federation


V. Kubyshkin
A.V. Vishnevsky Institute of Surgery, Moscow, Russia
Russian Federation


References

1. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2013 году. М., 2015. С. 9-15.

2. Широкорад В.И., Махсон А.Н., Ядыкова О.А. Состояние онкоурологической помощи в Москве, онкоурология. 2013. №4. С.11.

3. Bratslavsky G, Boris RS. Emerging Strategies of Nephron Sparing Surgery in Patients with Localized and Recurrent Renal Cell Carcinoma. // Malign Tumours 2010. №1. P. 5-14.

4. Gill I. Laparoscopic radical nephrectomy for cancer. // OrolClinNorth Am. 2000. №27. P. 707-719.

5. Клиническая онкоурология. Под редакцией профессора Б.П. Матвеева. - 2011. - М.: ООО «Издательский дом «АБВ-пресс». - С.76-77.

6. Go A. S, Chertow G. M, Fan D, McCulloch C. E, Hsu C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. // N Engl J Med. 2004. № 351. P. 1296.

7. Koenig P, Gill I.S, Kamoi K, Aron M, Haber G, Singh A.B, Weight CJ, Desai MM, Kaouk JH, Goldfarb DA, Poggio E.D. Kidney cancer and the risk for chronic kidney disease: matched-paired comparison with living donors. // The Journal of Urology. 2008. Vol. 179. P. 170.

8. McKiernan J, Simmons R, Katz J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. // Urology. 2002. Vol. 59. Р. 816.

9. System U. S. R. D.: Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), and US Department of Health and Human Services (DHHS). 2007

10. Foley R N, Parfrey P S, Sarnak M J. Clinical epidemiology of cardiovascular disease in chronic renal disease. // Am J Kidney Dis. 1998. Vol. 32. Р. 112.

11. Rocco M, Frankenfield DL, Hopson SK, McClellan WM: Relationship between clinical performance measures and outcomes among patients receiving longterm hemodialysis. // Ann Intern Med. 2006. Vol. 145. P. 512.

12. Neil N, Guest S, Wong L, Inglese G, Bhattacharyya S K, Gehr T. The financial implications for Medicare of greater use of peritoneal dialysis. // ClinTher. 2009. Vol. 31. P. 880.

13. Kasiske B L, Cangro C B, Hariharan S, Hricik D E, Kerman R H, Roth D. The evaluation of renal transplantation candidates: clinical practice guidelines. // Am J Transplant. 2001. № 3. Suppl 2.

14. Lin S J. The association between length of post-kidney transplant hospitalization and long-term graft and recipient survival. // Clin Transplant. 2006. № 20. Р. 245.

15. Джеральд Г.Д. Микич. Почечно-клеточный рак: экстракорпоральная резекция почки с последующей аутотрансплантацией при локализованной форме заболевания. // Онкоурология. 2007. №3. С. 16-20.

16. Clavien P, Sanabria J, Strasberg S. Proposed classification of complication of surgery with examples of utility in cholecystectomy. // Surgery. 1992. Vol. 111. P. 518 -526.

17. Bellinger MF, Koontz WW. Jr Smith MJ. Renal cell carcinoma: twenty years of experience. // Va Med. 1979. №106. Р.819—24.

18. Montie JE. «Bench surgery» for renal cell carcinoma: a proper niche. // Mayo Clin Proc. 1992. №67. Р. 701—2.

19. Petritsch PH, Gruber H, Colombo T. Indications and results of ex vivo surgery of the kidney. // Wien KlinWochenschr. 1995. Vol. 107. P. 731—5.

20. Stormont TJ, Bilhartz DL, Zincke H. Pitfalls of «bench surgery» and autotransplantation for renal cell carcinoma. // Mayo Clin Proc. 1992. №67. Р. 621—8.


Review

For citations:


Gritskevitch A., Il'in S., Timina I., Zotikov A., Karmazanovskiy G., Teplov A., Pokrovskiy A., Kubyshkin V. TECHNIQUE OF EXTRACORPOREAL PARTIAL NEPHRECTOMY IN TERMS OF PHARMACO-COLD ISCHEMIA WITHOUT CROSSING THE URETER WITH RENAL VESSELS ORTHOTOPIC REPLANTATION IN PATIENTS WITH RENAL CELL CARCINOMA. Urology Herald. 2015;(3):3-33. (In Russ.) https://doi.org/10.21886/2308-6424-2015-0-3-3-33

Views: 1444


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2308-6424 (Online)